International Clinical Trial: Bioequivalence test of trazodone sustained-release tablets

Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127834) titled 'Bioequivalence test of trazodone sustained-release tablets' on July 8.

Study Type: Interventional study

Study Design: Cross-over

Primary Sponsor: The Affiliated Panyu Central Hospital, Guangzhou Medical University

Condition: For depression with or without anxiety symptoms

Intervention: Fasting T-R Group:After an overnight fast, subjects received a single oral dose of 1 tablet (150 mg) of the test formulation (T), swallowed whole with approximately 240 mL of warm water. Seven days later, after an overnight fast, subjects received a single oral dose of 1 tablet (150 mg) of the reference formulation (R, TRITT...